{"id":4010,"date":"2023-10-25T12:17:22","date_gmt":"2023-10-25T12:17:22","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/"},"modified":"2026-10-12T14:16:26","modified_gmt":"2026-10-12T14:16:26","slug":"combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/","title":{"rendered":"Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumor responses and modulates the tumor immune microenvironment."},"content":{"rendered":"

Do you want to know how immune checkpoint inhibitors and radiotherapy and can work together to fight cancer?<\/p>\n

In our latest poster, we explored the effects of the immune checkpoint inhibitors in combination with fractionated radiotherapy on tumor growth in a syngeneic mouse model of colorectal cancer.<\/p>\n

We tested the combination of radiation with the immune checkpoint inhibitors PD1 and PD-L1 and found that it significantly increased therapeutic efficacy. With the use of flow cytometry, we characterized the changes in the tumor microenvironment and revealed how radiation and immunotherapy<\/a> can alter the balance of the infiltrated immune cells.<\/p>\n

Our work provides valuable insights into the mechanisms and outcomes of combining immunotherapy and radiotherapy for cancer treatment. It also offers a useful platform for testing new drugs and novel therapeutics that can potentially improve the efficacy and safety of this combination therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"

Explore our study on the synergy between immune checkpoint inhibitors and radiotherapy in treating colorectal cancer. We found that this combination significantly boosts efficacy, with flow cytometry revealing insightful changes in the tumor microenvironment. Our research opens the door to improved cancer therapies, offering a platform for testing new drugs and novel treatment approaches.<\/p>\n","protected":false},"featured_media":2682,"template":"","category":[685,751,738,688],"class_list":["post-4010","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-in-vivo-pharmacology","category-oncology","category-oncology-models","category-therapeutic-areas"],"acf":[],"yoast_head":"\nPD-1\/PD-L1 Blockade with Fractionated Radiotherapy<\/title>\n<meta name=\"description\" content=\"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumor responses and modulates the tumor immune microenvironment.\" \/>\n<meta property=\"og:description\" content=\"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-12T14:16:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster-no-4_IR-final-generic-QR-e1744810181915.png\" \/>\n\t<meta property=\"og:image:width\" content=\"628\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/\",\"name\":\"PD-1\\\/PD-L1 Blockade with Fractionated Radiotherapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster-no-4_IR-final-generic-QR-e1744810181915.png\",\"datePublished\":\"2023-10-25T12:17:22+00:00\",\"dateModified\":\"2026-10-12T14:16:26+00:00\",\"description\":\"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster-no-4_IR-final-generic-QR-e1744810181915.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster-no-4_IR-final-generic-QR-e1744810181915.png\",\"width\":628,\"height\":888},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumor responses and modulates the tumor immune microenvironment.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"alternateName\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/@sygnature.discovery\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sygnature-discovery\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PD-1\/PD-L1 Blockade with Fractionated Radiotherapy","description":"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/","og_locale":"fr_CA","og_type":"article","og_title":"Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumor responses and modulates the tumor immune microenvironment.","og_description":"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/","og_site_name":"Sygnature","article_modified_time":"2026-10-12T14:16:26+00:00","og_image":[{"width":628,"height":888,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster-no-4_IR-final-generic-QR-e1744810181915.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/","name":"PD-1\/PD-L1 Blockade with Fractionated Radiotherapy","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster-no-4_IR-final-generic-QR-e1744810181915.png","datePublished":"2023-10-25T12:17:22+00:00","dateModified":"2026-10-12T14:16:26+00:00","description":"Anti-tumor efficacy rose significantly in a syngeneic mouse model of colorectal cancer, with flow cytometry revealing shifts in the immune infiltrate.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster-no-4_IR-final-generic-QR-e1744810181915.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster-no-4_IR-final-generic-QR-e1744810181915.png","width":628,"height":888},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/combinations-of-immune-checkpoint-inhibitors-with-fractionated-radiotherapy-or-dna-damage-response-agents-leads-to-improved-anti-tumour-responses-and-modulates-the-tumour-immune-microenvironment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumor responses and modulates the tumor immune microenvironment."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","alternateName":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@sygnature.discovery","https:\/\/www.linkedin.com\/company\/sygnature-discovery\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":1,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4010\/revisions"}],"predecessor-version":[{"id":20737,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4010\/revisions\/20737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2682"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=4010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=4010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}